In addition, downregulation of ALKBH5 inhibited the stability of AKT2 mRNA following the treatment with actinomycin D (ActD, transcription inhibitor) in U87 glioma cells (Figure 7C). The gene discussed is AKT2; the disease is central nervous system cancer.